The diabetes-induced functional and distributional changes of the alpha 1-adrenoceptor of the abdominal aorta and distal mesenteric artery from streptozotocin-induced diabetic rats

Korean Journal of Anesthesiology

Volumn 60, Issue 4, 2011, Pages 272-281

  Lee, Jong Hwan ^a   Bahk, Jae Hyon ^b   Park, Sang Hyun ^c   Huh, Jin ^d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

Author keywords

Abdominal aorta; Alpha 1 adrenergic receptor; Diabetic complications; Experimental diabetes mellitus; Mesenteric artery; Streptozotocin

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ANTIBODY; PHENYLEPHRINE; STREPTOZOCIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISTAL MESENTERIC ARTERY; FLUORESCENCE; FLUORESCENT INTENSITY; IMMUNOFLUORESCENCE; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MUSCLE CONTRACTION; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 79955978863     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.60.4.272     Document Type: Article

References (30)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 Suppl 5: S1-85.
2. Watkins PJ, Thomas PK. Diabetes mellitus and the nervous system. J Neurol Neurosurg Psychiatry 1998; 65: 620-32.
3. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neouropathy. Diabetes Care 2003; 26: 1553-79.
4. Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. Br Med J 1982; 284: 928-30.
5. Flynn MD, Tooke JE. Diabetic neuropathy and the microcirculation. Diabet Med 1995; 12: 298-301.
6. Burgos LG, Elbert TJ, Asiddao C, Turner LA, Pattison CZ, Wang-Cheng R, et al. Increase intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989; 70: 591-7.
7. Langer SZ, Hicks PE. Alpha-adrenoceptor subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol 1884; 6 Suppl 4: S547-58.
8. Ruffolo RR Jr, Hieble JP, Brooks DP, Feurstein GZ, Nichols AJ. Drug receptors and control of the cardiovascular system: recent advances. Prog Drug Res 1991; 36: 117-360.
9. Jarajapu YP, Coats P, McGrath JC, Hiller C, MacDonald A. Functional characterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteries. Br J Pharmacol 2001; 133: 679-86.
10. Vargas HM, Gorman AJ. Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci 1995; 57: 2291-308.
11. Koshimizu TA, Tanoue A, Hirasawa A, Yamauchi J, Tsujimoto G. Recent advances in alpha 1-adrenoceptor pharmacology. Pharmacol Ther 2003; 98: 235-44.
12. Civantos Calzada B, Aleixandre de Artiñano A. Alpha-adrenoceptor subtypes. Pharmacol Res 2001; 44: 195-208.
13. Agrawal DK, McNeill JH. Effect of diabetes on vascular smooth muscle function in normotensive and spontaneously hypertensive rat mesenteric artery. Can J Physiol Pharmacol 1987; 65: 2274-80.
14. Kam KL, Hendriks MG, Piji AJ, van Marle J, van Veen HA, Pfaffendorf M, et al. Contractile responses to various stimuli in isolated resistance vessels from simultaneously hypertensive and streptozotocin-diabetic rats. J Cardiovasc Pharmacol 1996; 27: 167-75.
15. Beenen OH, Mathy MJ, Pfaffendorf M, van Zwieten PA. Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J Hypertens 1996; 14: 1125-30.
16. Schild HO. pA, a new scale for the measurement of drug antagonism. Br J Pharmacol 1947; 2: 189-206.
17. McGrath JC. Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem Pharmacol 1982; 31: 467-84.
18. Arévalo-León LE, Gallardo-Ortíz IA, Urquiza-Marín H, VillalobosMolina R. Evidence for the role of alpha1D- and alpha1Aadrenoceptors in contraction of the rat mesenteric artery. Vascul Pharmacol 2003; 40: 91-6.
19. Martí D, Miquel R, Ziani K, Gisbert R, Ivorra MD, Anselmi E, et al. Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. Am J Physiol Heart Circ Physiol 2005; 289: H1923-32.
20. Asbún-Bojalil J, Castillo EF, Escalante BA, Castillo C. Does segmental difference in alpha 1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae? Vascul Pharmacol 2002; 38: 169-75.
21. Wong KK. A significant increase of aortic response to a combination of norepinephrine and KCl in aorta isolated from 2-month diabetic rats induced by streptozotocin. Artery 1996; 22: 164-71.
22. Mahmoudian M, Benhaz F, Rezaei E. Diabetes-induced changes in the contractility of the aorta and pA2 of nifedipine in the rat. Acta Diabetol 1996; 33: 114-7.
23. Nobe K, Sakai Y, Maruyama Y, Momose K. Hyper-reactivity of diacylglycerol kinase is involved in the dysfunction of aortic smooth muscle contractility in streptozotocin-induced diabetic rats. Br J Pharmacol 2002; 136: 441-51.
24. Schylingkamp RJ, Vincent A, Tallarida RJ, Raffa RB. Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology 2005; 74: 23-30.
25. Abebe W, Harris KH, MacLeod KM. Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 1990; 16: 239-48.
26. Abebe W, MacLeod KM. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with phosphoinositide metabolism. Can J Physiol Pharmacol 1991; 69: 355-61.
27. Wong KK. A significant increase of aortic response to a combination of norepinephrine and KCl in aorta isolated from 2-month diabetic rats induced by streptozotocin. Artery 1996; 22: 164-71.
28. Brøndum E, Nilsson H, Aalkjaer C. Functional abnormalities in isolated arteries from Goto-Kakizaki and Streptozotocin-treated diabetic rat models. Horm Metab Res 2005; 37 Suppl 1: 56-60.
29. Makino A, Kamata K. Possible modulation by endothelin-1, nitric oxide, prostaglandin 12 and thromboxane A2 of vasoconstriction induced by an alpha-agonist in mesenteric arterial bed from diabetic rats. Diabetologia 1998; 41: 1410-8.
30. Jensen BC, Swigart PM, Simpson PC. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 409-12.